Rate of telomere shortening and cardiovascular damage: a longitudinal study in the 1946 British Birth Cohort
Author(s)
Type
Journal Article
Abstract
Aim Cross-sectional studies reported associations between short leucocyte telomere length (LTL) and measures of vascular and cardiac damage. However, the contribution of LTL dynamics to the age-related process of cardiovascular (CV) remodelling remains unknown. In this study, we explored whether the rate of LTL shortening can predict CV phenotypes over 10-year follow-up and the influence of established CV risk factors on this relationship.
Methods and results All the participants from the MRC National Survey of Health and Development (NSHD) with measures of LTL and traditional CV risk factors at 53 and 60–64 years and common carotid intima-media thickness (cIMT), cardiac mass and left ventricular function at 60–64 years were included. LTL was measured by real-time polymerase chain reaction and available at both time points in 1033 individuals. While LTL at 53 years was not linked with any CV phenotype at 60–64 years, a negative association was found between LTL and cIMT at 60–64 years (β = −0.017, P = 0.015). However, the strongest association was found between rate of telomere shortening between 53 and 60–64 years and values of cIMT at 60–64 years (β = −0.020, P = 0.006). This association was not affected by adjustment for traditional CV risk factors. Cardiac measurements were not associated with cross-sectional or longitudinal measures of LTL.
Conclusion These findings suggest that the rate of progression of cellular ageing in late midlife (reflected by the rate of LTL attrition) relates to vascular damage, independently from contribution of CV risk factor exposure.
Methods and results All the participants from the MRC National Survey of Health and Development (NSHD) with measures of LTL and traditional CV risk factors at 53 and 60–64 years and common carotid intima-media thickness (cIMT), cardiac mass and left ventricular function at 60–64 years were included. LTL was measured by real-time polymerase chain reaction and available at both time points in 1033 individuals. While LTL at 53 years was not linked with any CV phenotype at 60–64 years, a negative association was found between LTL and cIMT at 60–64 years (β = −0.017, P = 0.015). However, the strongest association was found between rate of telomere shortening between 53 and 60–64 years and values of cIMT at 60–64 years (β = −0.020, P = 0.006). This association was not affected by adjustment for traditional CV risk factors. Cardiac measurements were not associated with cross-sectional or longitudinal measures of LTL.
Conclusion These findings suggest that the rate of progression of cellular ageing in late midlife (reflected by the rate of LTL attrition) relates to vascular damage, independently from contribution of CV risk factor exposure.
Date Issued
2014-12-07
Date Acceptance
2014-06-22
Citation
European Heart Journal, 2014, 35 (46), pp.3296-3303
ISSN
1522-9645
Publisher
Oxford University Press
Start Page
3296
End Page
3303
Journal / Book Title
European Heart Journal
Volume
35
Issue
46
Copyright Statement
© The Author 2014. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
License URL
Subjects
Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
Ageing
Telomeres shortening
Cardiovascular diseases
Carotid artery
INTIMA-MEDIA THICKNESS
AMERICAN-SOCIETY
VASCULAR-DISEASE
OLDEST-OLD
LENGTH
HEART
ATHEROSCLEROSIS
ASSOCIATION
BIOLOGY
RISK
Cardiovascular Diseases
Carotid Artery Diseases
Carotid Intima-Media Thickness
Cell Aging
Disease Progression
Female
Humans
Leukocytes
Longitudinal Studies
Male
Middle Aged
Phenotype
Risk Factors
Telomere Shortening
NSHD scientific and data collection teams
Cardiovascular System & Hematology
1102 Cardiovascular Medicine And Haematology
Publication Status
Published